Deval A. Lashkari, Senior Partner at Telegraph Hill Partners, San Francisco Bay Area, California. See sector focus and contact routes.
Deval A. Lashkari is a co-founder and Senior Partner at Telegraph Hill Partners (THP), a San Francisco-based venture firm where he has worked since 2001 leveraging over 25 years of life sciences experience as an entrepreneur and senior executive. THP invests primarily in life sciences and healthcare companies across stages ranging from seed and first rounds to pre-IPO and buyouts, with a broad sector focus including biotechnology, medical equipment, and software. The firm manages less than $150 million in assets across seven private funds, though Lashkari’s specific check size and lead/follow behavior are not publicly disclosed. His notable portfolio includes board directorships at EditCo Bio, Panome Bio, Mosaic Biosciences, and Carterra, with THP providing growth capital to Panome Bio to expand its metabolomics and proteomics business. Lashkari holds a PhD in Genetics from Stanford University and serves as President of the Stanford Medical School Alumni Board of Governors, reflecting his deep roots in the academic-medical ecosystem. No distinctive public writing or unique investment point of view beyond his life sciences specialization is documen
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco Bay Area.
Investors like Deval A. Lashkari · Full investor directory · Investor access · Company funding database